Home
Conditions
Herpesviridae Infections

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

NCT00000769

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: UCLA CARE Center CRS Los Angeles, California, United States

Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States

Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States

View Trial Details

Completed

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

NCT00000673

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations: Univ. of Miami AIDS CRS Miami, Florida, United States

Washington U CRS St Louis, Missouri, United States

View Trial Details

Completed

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

NCT01535885

Conditions: Adenoviridae Infections, Adenovirus, Cytomegalovirus Infections, +6 more
Locations: Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

NCT02265913

Conditions: DNA Virus Infections, Herpes Labialis, Herpes Simplex, +10 more
Locations: Quality Clinical Research Inc Omaha, Nebraska, United States

View Trial Details

Completed

Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)

NCT00432523

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: France

Germany

View Trial Details

Completed

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

NCT02808442

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

University of Texas Southwestern Medical Center Dallas, Texas, United States

Hôpital Robert-Debré Paris, France

View Trial Details

Completed

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

Hôpital Saint-Louis Paris, France

View Trial Details

Completed

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

NCT00424242

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

NCT01552369

Conditions: Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytomegalovirus Infection, +11 more
Locations: Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States

Emory Clinic - Transplant Center Atlanta, Georgia, United States

Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States

Mount Sinai School of Medicine - Medicine - Infectious Diseases New York, United States

View Trial Details

Completed

10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00052442

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Herpesviridae Infections

Herpesviridae Infections trial results

Related conditions